BioCentury
ARTICLE | Finance

Biotech trio’s NASDAQ debuts push year’s IPO haul past $13B

Berkeley Lights caps off $178M raise with a nearly 200% stock gain

July 18, 2020 1:28 AM UTC

A trio of biotechs raised about $475 million in their public debuts late Thursday, bringing the total IPO cash raised in 2020 to $13.3 billion across 56 biopharma offerings. Berkeley Lights led the group with a $178.2 million raise, and a triple-digit gain on its first day of trading.

All three companies -- Berkeley Lights Inc. (NASDAQ:BLI), ALX Oncology Holdings Inc. (NASDAQ:ALXO) and Pandion Therapeutics Inc. (NASDAQ:PAND) -- upsized the number of shares sold. The former two biotechs priced above their proposed ranges...